CoChat

Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial

Open access

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Background: The continued increase in prevalence of methamphetamine use in the United States has resulted in a significant increase in the number of patients entering treatment for methamphetamine use. However, no robustly efficacious pharmacologic treatment for methamphetamine use or withdrawal has been identified to date after stopping methamphetamine use. Aims: Given the association between methamphetamine withdrawal and relapse during early treatment, this study tested a controlled d-amphetamine withdrawal paradigm among methamphetamine-using individuals. Methods: Treatment-seeking adults who used methamphetamine ( N = 34; 47% female; 100% white) were enrolled in a 4-week, randomized, double-blind, placebo-controlled trial in a residential setting, in which all participants were maintained on d-amphetamine (30 mg BID) during week 1, then half were switched to placebo during weeks 2–3. All participants received placebo during week 4. Outcomes included vital signs, withdrawal, cravings for methamphetamine, mood, and cognition. Bivariate analyses tested treatment group differences on baseline demographic and outcome variables. Repeated measures models examined main and interaction effects of treatment over time. Results/Outcomes: Participants were successfully randomized and safely stabilized on d-amphetamine. Craving for methamphetamine increased during weeks 2–3 in the placebo group relative to those on d-amphetamine. Interactions with age and heart rate were noted. Conclusions/Interpretation: To our knowledge, this is the first double-blind, placebo-controlled trial measuring pharmacologic effects of abruptly stopping controlled d-amphetamine administration in adults who use methamphetamine. Results support the potential of this withdrawal paradigm to further examine the efficacy of pharmacologic agents in ameliorating methamphetamine withdrawal symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/02698811211050563

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. DHHS and SAMHSA (2019) Results from the 2019 National Survey on Drug Use and Health: National Findings in: Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies: Rockville, MD.

Cited by

See all 12

Metadata

Authors
Thompson, R. G., Oliveto, A., Thostenson, J. D., Wilson, M. P., McGaugh, J., & Mancino, M. J.
Affiliations
  • University of Arkansas for Medical Sciences (US)
  • Ouachita Behavioral Health and Wellness, Hot Springs, AR, USA
Venue
Journal of Psychopharmacology
Published
2021-10-26
Volume
35
Issue
11
Pages
1420-1430
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W3210879314
Cited by
12
References
37
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 2
FWCI
1.44
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Center for Research Resources (NCRR-RR020146)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
methamphetamine use, amphetamine withdrawal, d-amphetamine, craving, relapse prevention, heart rate, mood, cognition, residential treatment
MeSH terms
Adult, Central Nervous System Stimulants, Dextroamphetamine, Double-Blind Method, Female, Humans, Male, Methamphetamine, Pilot Projects, Substance Withdrawal Syndrome, Amphetamine-Related Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial. https://app.cochat.ai/papers/10.1177/02698811211050563
The paper
Thompson, R. G., Oliveto, A., Thostenson, J. D., Wilson, M. P., McGaugh, J., & Mancino, M. J. (2021). Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial. Journal of Psychopharmacology. https://doi.org/10.1177/02698811211050563

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.